SWOG clinical trial number
              SWOG-8808
          A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Chronic Myeloid Leukemia
Closed
      
  Phase
              Accrual
  
                          
      0%
      
  
    Abbreviated Title
              A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Chronic Myeloid Leukemia
          Activated
              11/15/1989
          Closed
              11/15/1990
          